Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain

References

• Arrang JM, Devaux B, Chodkiewicz JP, Schwartz JC. 1988. H3-receptors control histamine release in human brain. J Neurochem. 51:105–108.
   PubMed Web of Science ®Google Scholar
• Arrang JM, Garbarg M, Schwartz JC. 1985. Autoregulation of histamine release in brain by presynaptic H3-receptors. Neuroscience. 15:553–562.
   PubMed Web of Science ®Google Scholar
• Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 21:263–265.
   PubMed Web of Science ®Google Scholar
• De Hert M, Detraux J, van Winkel R, Yu W, Correll CU. 2012. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol. 8:114–126.
   Web of Science ®Google Scholar
• Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol. 25:115–121.
   PubMed Web of Science ®Google Scholar
• Dudbridge F. 2008. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered. 66:87–98.
   PubMed Web of Science ®Google Scholar
• Ferno J, Varela L, Skrede S, Vazquez MJ, Nogueiras R, Dieguez C, Vidal-Puig A, Steen VM, Lopez M. 2011. Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS One. 6:e20571.
   PubMed Web of Science ®Google Scholar
• Gauderman WJ, Morrison JM. 2006. A computer program for power and sample size calculations for genetic-epidemiology studies. Available from: http://hydra.usc.edu/gxe.
   Google Scholar
• Global Lipids Genetics Consortium, Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, Ganna A, Chen J, Buchkovich ML, et al. 2013. Discovery and refinement of loci associated with lipid levels. Nat Genet. 45:1274–1283.
   PubMed Web of Science ®Google Scholar
• Goldman S, Zhang Y, Jin S. 2010. Autophagy and adipogenesis: implications in obesity and type II diabetes. Autophagy. 6:179–181.
   PubMed Web of Science ®Google Scholar
• HaploReg version 4.1. Available from: http://www.broadinstitute.org/mammals/haploreg/haploreg.php.
   Google Scholar
• He M, Zhang Q, Deng C, Wang H, Huang XF. 2014. Olanzapine-activated AMPK signaling in the dorsal vagal complex is attenuated by histamine H1 receptor agonist in female rats. Endocrinology. 155:4895–4904.
   PubMed Web of Science ®Google Scholar
• Humbert-Claude M, Davenas E, Gbahou F, Vincent L, Arrang JM. 2012. Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo. Psychopharmacology (Berlin). 220:225–241.
   PubMed Web of Science ®Google Scholar
• International HapMap Consortium. 2003. The international HapMap project. Nature. 426:789–796.
   PubMed Web of Science ®Google Scholar
• Kim SF, Huang AS, Snowman AM, Teuscher C, Snyder SH. 2007. From the cover: antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase. Proc Natl Acad Sci USA. 104:3456–3459.
   PubMed Web of Science ®Google Scholar
• Kosoy R, Nassir R, Tian C, White PA, Butler LM, Silva G, Kittles R, Alarcon-Riquelme ME, Gregersen PK, Belmont JW, et al. 2009. Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat. 30:69–78.
   PubMed Web of Science ®Google Scholar
• Kroeze WK, Hufeisen SJ, Popadak BA, Renock SM, Steinberg S, Ernsberger P, Jayathilake K, Meltzer HY, Roth BL. 2003. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology. 28:519–526.
   PubMed Web of Science ®Google Scholar
• Lahiri DK, Nurnberger JI, Jr. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19:5444.
   PubMed Web of Science ®Google Scholar
• Lecklin A, Etu-Seppala P, Stark H, Tuomisto L. 1998. Effects of intracerebroventricularly infused histamine and selective H1, H2 and H3 agonists on food and water intake and urine flow in Wistar rats. Brain Res. 793:279–288.
   PubMed Web of Science ®Google Scholar
• Lett TA, Wallace TJ, Chowdhury NI, Tiwari AK, Kennedy JL, Müller DJ. 2012. Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Mol Psychiatry. 17:242–266.
   PubMed Web of Science ®Google Scholar
• Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. 2009. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 373:31–41.
   PubMed Web of Science ®Google Scholar
• Lian J, Huang XF, Pai N, Deng C. 2016. Ameliorating antipsychotic-induced weight gain by betahistine: mechanisms and clinical implications. Pharmacol Res. 106:51–63.
   PubMed Web of Science ®Google Scholar
• Masellis M, Basile V, Meltzer HY, Lieberman JA, Sevy S, Macciardi FM, Cola P, Howard A, Badri F, Nothen MM, et al. 1998. Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmacology. 19:123–132.
   PubMed Web of Science ®Google Scholar
• Müller DJ, Kennedy JL. 2006. Genetics of antipsychotic treatment emergent weight gain in schizophrenia. Pharmacogenomics. 7:863–887.
   PubMed Web of Science ®Google Scholar
• Nyholt DR. 2004. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet. 74:765–769.
   PubMed Web of Science ®Google Scholar
• Palavicino-Maggio CB, Kuzhikandathil EV. 2016. Dietary fructose and GLUT5 transporter activity contribute to antipsychotic-induced weight gain. Schizophr Bull. 42:1270–1279.
   PubMed Web of Science ®Google Scholar
• Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 81:559–575.
   PubMed Web of Science ®Google Scholar
• Ratliff JC, Barber JA, Palmese LB, Reutenauer EL, Tek C. 2010. Association of prescription H1 antihistamine use with obesity: results from the National Health and Nutrition Examination Survey. Obesity (Silver Spring). 18:2398–2400.
   PubMed Web of Science ®Google Scholar
• Reynolds GP. 2012. Histamine and antipsychotic drug-induced weight gain. J Psychopharmacol (Oxford). 26:1608–1609.
   PubMed Web of Science ®Google Scholar
• Reynolds GP, Kirk SL. 2010. Metabolic side effects of antipsychotic drug treatment-pharmacological mechanisms. Pharmacol Ther. 125:169–179.
   PubMed Web of Science ®Google Scholar
• Roadmap Epigenomics Consortium, Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, Heravi-Moussavi A, Kheradpour P, Zhang Z, Wang J, et al. 2015. Integrative analysis of 111 reference human epigenomes. Nature. 518:317–330.
   PubMed Web of Science ®Google Scholar
• Sakata T, Ookuma K, Fukagawa K, Fujimoto K, Yoshimatsu H, Shiraishi T, Wada H. 1988. Blockade of the histamine H1-receptor in the rat ventromedial hypothalamus and feeding elicitation. Brain Res. 441:403–407.
   PubMed Web of Science ®Google Scholar
• Salvi V, Mencacci C, Barone-Adesi F. 2016. H1-histamine receptor affinity predicts weight gain with antidepressants. Eur Neuropsychopharmacol. 26:1673–1677.
   PubMed Web of Science ®Google Scholar
• Tiwari AK, Brandl EJ, Weber C, Likhodi O, Zai CC, Hahn MK, Lieberman JA, Meltzer HY, Kennedy JL, Muller DJ. 2013. Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients. J Clin Psychopharmacol. 33:11–17.
   PubMed Web of Science ®Google Scholar
• Tiwari AK, Brandl EJ, Zai CC, Goncalves VF, Chowdhury NI, Freeman N, Lieberman JA, Meltzer HY, Kennedy JL, Muller DJ. 2016. Association of orexin receptor polymorphisms with antipsychotic-induced weight gain. World J Biol Psychiatry. 17:221–229.
   PubMed Web of Science ®Google Scholar
• Tiwari AK, Zai CC, Likhodi O, Lisker A, Singh D, Souza RP, Batra P, Zaidi SH, Chen S, Liu F, et al. 2010. A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia. Neuropsychopharmacology. 35:1315–1324.
   PubMed Web of Science ®Google Scholar
• Vehof J, Risselada AJ, Al Hadithy AF, Burger H, Snieder H, Wilffert B, Arends J, Wunderink L, Knegtering H, Wiersma D, et al. 2011. Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication. Psychopharmacology (Berlin). 216:257–265.
   PubMed Web of Science ®Google Scholar
• Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA. 2002. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry. 159:255–262.
   PubMed Web of Science ®Google Scholar
• Ward LD, Kellis M. 2012. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40:D930–D934.
   PubMed Web of Science ®Google Scholar
• World health Organization (WHO). 2016. Mental health-Schizophrenia. Available from http://www.who.int/mental_health/management/schizophrenia/en/.
   Google Scholar
• Zhang JP, Lencz T, Zhang RX, Nitta M, Maayan L, John M, Robinson DG, Fleischhacker WW, Kahn RS, Ophoff RA, et al. 2016. Pharmacogenetic associations of antipsychotic drug-related weight gain: a systematic review and meta-analysis. Schizophr Bull. 42:1418–1437.
   PubMed Web of Science ®Google Scholar